book, page-149

Sincerely, I would prefer a sort of agreement that allows us to build value in additional one-two more years and so staying alive for another while, instead to be just eaten now at 0.35-0.40.
We should get a partner agreement and a cash infusion, that let us run with all our pipeline to the road of success. Already such a good news would move the sp to new supported levels.
If we get bought now, we disappear as a listed company, as the technology will pass in the Big Pharma shelves.

I am looking something similar to the Pharmacycles/Johnson/Abbvie story.
A company that from 1 USD was sold in the end at about $240.